These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1282887)

  • 1. A mutant of human insulin-like growth factor II (IGF II) with the processing sites of proinsulin. Expression and binding studies of processed IGF II.
    Zarn JA; Lüthi C; Giger RJ; Sigrist A; Humbel RE
    Eur J Biochem; 1992 Dec; 210(3):665-9. PubMed ID: 1282887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants.
    Lüthi C; Roth BV; Humbel RE
    Eur J Biochem; 1992 Apr; 205(2):483-90. PubMed ID: 1374027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
    Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF
    Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6.
    Bach LA; Hsieh S; Sakano K; Fujiwara H; Perdue JF; Rechler MM
    J Biol Chem; 1993 May; 268(13):9246-54. PubMed ID: 7683646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
    Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
    Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions.
    Hashimoto R; Fujiwara H; Higashihashi N; Enjoh-Kimura T; Terasawa H; Fujita-Yamaguchi Y; Inagaki F; Perdue JF; Sakano K
    J Biol Chem; 1995 Jul; 270(30):18013-8. PubMed ID: 7629109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67.
    Roth BV; Bürgisser DM; Lüthi C; Humbel RE
    Biochem Biophys Res Commun; 1991 Dec; 181(2):907-14. PubMed ID: 1721812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. Localization of the insulin-like growth factor II binding site to domains 5-11.
    Dahms NM; Wick DA; Brzycki-Wessell MA
    J Biol Chem; 1994 Feb; 269(5):3802-9. PubMed ID: 8106425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
    Hodgson DR; May FE; Westley BR
    Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor.
    Sakano K; Enjoh T; Numata F; Fujiwara H; Marumoto Y; Higashihashi N; Sato Y; Perdue JF; Fujita-Yamaguchi Y
    J Biol Chem; 1991 Nov; 266(31):20626-35. PubMed ID: 1657932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues.
    Zaccheo OJ; Prince SN; Miller DM; Williams C; Kemp CF; Brown J; Jones EY; Catto LE; Crump MP; Hassan AB
    J Mol Biol; 2006 Jun; 359(2):403-21. PubMed ID: 16631789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of the insulin-like growth factor II binding site to amino acids 1508-1566 in repeat 11 of the mannose 6-phosphate/insulin-like growth factor II receptor.
    Schmidt B; Kiecke-Siemsen C; Waheed A; Braulke T; von Figura K
    J Biol Chem; 1995 Jun; 270(25):14975-82. PubMed ID: 7797478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-IL-overexpressing NIH 3T3 cells.
    Claussen M; Buergisser D; Schuller AG; Matzner U; Braulke T
    Mol Endocrinol; 1995 Jul; 9(7):902-12. PubMed ID: 7476972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards identification of a binding site on insulin-like growth factor-II for IGF-binding proteins.
    Bach LA; Hsieh S; Sakano K; Fujiwara H; Perdue JF; Rechler MM
    Adv Exp Med Biol; 1993; 343():55-61. PubMed ID: 7514352
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-function studies of an IGF-I analogue that can be chemically cleaved to a two-chain mini-IGF-I.
    Geddes S; Holst P; Grotzinger J; Gill R; Nugent P; De Meyts P; Wollmer A; Wood S; Pitts J
    Protein Eng; 2001 Jan; 14(1):61-5. PubMed ID: 11287679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification, and in vitro characterization of recombinant salmon insulin-like growth factor-II.
    Wilkinson RJ; Elliott P; Carragher JF; Francis G
    Protein Expr Purif; 2004 Jun; 35(2):334-43. PubMed ID: 15135411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
    Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
    Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-II (IGF-II), type 2 IGF receptor, and IGF-binding protein-2 gene expression in rat lung alveolar epithelial cells: relation to proliferation.
    Mouhieddine OB; Cazals V; Maitre B; Le Bouc Y; Chadelat K; Clement A
    Endocrinology; 1994 Jul; 135(1):83-91. PubMed ID: 7516870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.